BCR-ABL-expressing DCs appear to inefficiently to induce CML-specific T cell responses resulting from low DC maturation and impaired homing to secondary lymphoid organs. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.